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Abstract. 
 
In 
 
C
 
.
 
 elegans
 
, assembly of hypodermal 
hemidesmosome-like structures called ﬁbrous or-
ganelles is temporally and spatially coordinated with 
the assembly of the muscle contractile apparatus, sug-
gesting that signals are exchanged between these cell 
types to position ﬁbrous organelles correctly. Myotac-
tin, a protein recognized by monoclonal antibody 
MH46, is a candidate for such a signaling molecule. The 
antigen, although expressed by hypodermis, ﬁrst re-
ﬂects the pattern of muscle elements and only later re-
ﬂects the pattern of ﬁbrous organelles. Confocal mi-
croscopy shows that in adult worms myotactin and 
ﬁbrous organelles show coincident localization. Fur-
ther, cell ablation studies show the bodywall muscle 
cells are necessary for normal myotactin distribution. 
To investigate myotactin’s role in muscle-hypodermal 
signaling, we characterized the myotactin locus molecu-
larly and genetically. Myotactin is a novel transmem-
 
brane protein of 
 
z
 
500 kd. The extracellular domain 
contains at least 32 ﬁbronectin type III repeats and the 
cytoplasmic domain contains unique sequence. In mu-
tants lacking myotactin, muscle cells detach when em-
bryonic muscle contraction begins. Later in develop-
ment, ﬁbrous organelles become delocalized and are 
not restricted to regions of the hypodermis previously 
contacted by muscle. These results suggest myotactin 
helps maintain the association between the muscle con-
tractile apparatus and hypodermal ﬁbrous organelles.
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T
 
HROUGHOUT
 
 the bodies of complex multicellular
organisms, different cell types must interact to form
the organs and tissues necessary for diverse biologi-
cal functions. One of the best-characterized examples
where different cell types coordinate their behaviors to
achieve a specific function occurs at the neuromuscular
junction where a nerve and muscle cell function together
during synaptic transmission, an event requiring the cor-
rect spatial relationship between pre- and post-synaptic
protein complexes. This relationship is initiated by contact
between the muscle and nerve, and is established through
a signaling pathway involving the basement membrane
protein agrin (reviewed in 10, 23) and a muscle-specific ki-
nase (14).
 
Similarly, in 
 
Caenorhabditis elegans
 
,
 
 
 
bodywall muscles
and the hypodermis function coordinately during locomo-
tion. The contractile apparatus of the bodywall muscle
consists of thick and thin filaments that slide past each
other to create force. During locomotion, the force gener-
ated by the contractile apparatus must be transmitted
through the hypodermis to the cuticular exoskeleton. This
is achieved through a specialized basement membrane sit-
uated between the muscle cells and hypodermis, and
through hypodermal cell adhesion structures called fi-
brous organelles (22). Together with muscle and muscle
membrane proteins, the basement membrane and the fi-
brous organelles form a molecular link between the con-
tractile apparatus and the cuticle (21, 22).
Each hypodermal fibrous organelle is made up of two
 
substructures, both of which are morphologically simi-
lar to vertebrate hemidesmosomes (22). Like vertebrate
hemidesmosomes, the substructures have the classical
membrane plaque and associated intermediate filaments
(22, 48). One hemidesmosome-like plaque of each fibrous
organelle is found on the hypodermal membrane adjacent
to the muscle basement membrane, and the other is found
on the hypodermal membrane adjacent to the cuticle (22).
The associated intermediate filaments extending between
the plaques on either surface probably span the cells.
The bodywall muscle contractile apparatus and the hy-
podermal fibrous organelles are closely associated (see
Fig. 1 A). The contractile apparatus is positioned at the
muscle cell membrane that faces the hypodermis (re-
viewed in 55) and fibrous organelles are localized to re-
gions of the hypodermis adjacent to muscle (22). These
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types of spatial and functional relationships between struc-
tures in different cells suggest signals are passed between
the cells to establish the association, and that molecules
exist to maintain the correct alignment of the structures
during the life of the organism.
The molecular link between the contractile apparatus
and the fibrous organelles is set up during embryogenesis
and, like the neuromuscular junction, appears to be initi-
ated by cell–cell contact (30; summarized in Fig. 1 B). Dur-
ing embryogenesis, the post-mitotic developing muscle
cells migrate from their initial position adjacent to the lat-
eral hypodermal cells onto the neighboring dorsal and
ventral hypodermal cells. Components of the muscle con-
tractile apparatus, which are until this time diffusely dis-
tributed, coalesce at the membrane near the point of con-
tact with the dorsal/ventral hypodermal cells. Similarly,
and within minutes, the fibrous organelle components,
which are initially diffusely distributed in the hypodermis,
coalesce in the hypodermis adjacent to muscle. Through-
out further development, the components of the fibrous
organelles remain restricted to the small portion of the
dorsal and ventral syncytial hypodermis adjacent to mus-
cle cells (30). The single exception is that in larval stages,
when mechanosensory neurons develop, fibrous organ-
elles also appear overlying these neuronal processes (22).
These neuron-associated fibrous organelles play an adhe-
sion role similar to that of the muscle-associated fibrous
organelles, affixing the neuron to the cuticle.
Both the myofilament lattice and the fibrous organelles
assemble in specific and different patterns as development
continues. The muscle proteins show an oblique longitudi-
nal striation (reviewed in 55) and the fibrous organelles
become organized in circumferentially oriented, regularly
spaced bands, limited to regions of the hypodermis adja-
cent to muscle cells (22). Each hypodermal band consists
of multiple smaller complexes, each corresponding to a fi-
brous organelle. The spacing of the fibrous organelle–con-
taining bands correlates with the spacing of cuticular
ridges called annuli.
Three proteins that reflect the fibrous organelle pattern
of organization have been identified immunologically (22).
All three localize to small dots which together form a
banded pattern in regions of the hypodermis which are
known to contain fibrous organelles by electron micro-
scopic analysis (22; see also Fig. 8 A). One is an intermedi-
ate filament subunit recognized by monoclonal antibody
MH4 and by the antibody IFA raised against mammalian
intermediate filaments (22). The other two proteins, rec-
ognized by MH5 and MH46, respectively, are large and
are closely associated with the hypodermal membrane.
The MH5 protein is found at both the cuticular and the
muscle basement membrane surfaces of the hypodermis
while the MH46 protein is specific for the muscle base-
ment membrane surface (22). As will be discussed, the
MH46 protein plays a role in muscle–cell adhesion and
therefore we have named the protein myotactin. Interme-
diate filaments, myotactin, and the MH5 protein are also
found in the pharynx, an organ at the anterior of the worm
used in feeding (1, 6, 22).
The change in the myotactin staining pattern as devel-
opment progresses suggests it might be involved in estab-
lishing or maintaining the correct spatial relationship be-
 
tween the contractile apparatus and hypodermal fibrous
organelles. Unlike the MH4-containing intermediate fila-
ments and the MH5 protein, myotactin appears to colocal-
ize with muscle proteins early in embryonic development,
and only later organizes into the circumferential bands of
the fibrous organelles (30; see Fig. 1 B). In this study, con-
focal microscopy was used to show that myotactin local-
izes at or near fibrous organelles in adult 
 
C
 
.
 
 elegans
 
. We
also show that the early muscle-like distribution of myo-
tactin depends on signals from the bodywall muscle cells.
To investigate the role myotactin plays in muscle-hypoder-
mal signaling, we have begun a molecular and genetic
characterization of the myotactin gene. We have cloned
and sequenced cDNAs that encode myotactin, and charac-
terized mutants in the corresponding gene. The sequence
suggests myotactin is a transmembrane protein containing
at least 32 fibronectin type III (FNIII)
 
1
 
 repeats extracellu-
larly and unique sequences intracellularly. The phenotype
of the mutants suggests myotactin is involved in muscle
cell attachment and possibly in maintaining the position of
the fibrous organelles within regions of the hypodermis
adjacent to muscle.
 
Materials and Methods
 
Strains and General Maintenance of Stocks
 
Worms were grown on bacterial strain OP50 spread on NGM (nematode
growth media) agar plates according to Brenner (11). The Bristol variety
of the N2 strain of 
 
C
 
.
 
 elegans
 
 is used as the wild-type strain, and the geno-
types of the mutant strains used are as follows: RW3625, 
 
let-805(st456)/
qC1
 
; BC4534, 
 
unc-45(rh450)let-805(s2764)/sC1
 
; and 
 
let-805(st456)/dpy-
1(e1)daf-2(e1370)
 
.
 
Cloning
 
A clone encoding an MH46 epitope was isolated from a genomic library
made from randomly sheared 
 
C
 
.
 
 elegans 
 
DNA cloned into the vector
 
l
 
gt11 (4). The screen was performed according to Maniatis (36) with a few
exceptions. Filters were washed in TTBS (20 mM Tris, pH 7.5, 150 mM
NaCl, 0.05% Tween 20) and blocked in TTBS containing 1% normal goat
serum (GIBCO BRL) and 5% fish gelatin (Sigma). The MH46 primary
antibody was detected using alkaline phosphatase-conjugated goat anti–
mouse IgG (Tago) diluted 1:2,500 in block buffer and the secondary anti-
body was localized using 0.137 mg/ml 5-bromo-4-chloro-3-indolyl phos-
phate (Sigma), 0.33 mg/ml nitro blue tetrazolium (Sigma) and 0.013 mg/ml
phenazine methosulfate (Sigma) according to Ey and Ashman (19). One
clone (
 
l
 
G-cc9) was obtained from a screen of 10
 
6
 
 PFU.
The genomic fragment from 
 
l
 
G-cc9 was labeled using the Prime-It-II
kit (Stratagene) and 
 
a
 
-P
 
32
 
-labeled ATP (Amersham) according to Strat-
agene. The labeled DNA was used to screen a randomly primed cDNA li-
brary made from RNA of mixed stage worms and cloned into the pACT
vector. The screen was performed according to Maniatis (36) except hy-
bridizations were done in 6
 
3 
 
SSC, 1% SDS, and 100 mg/ml salmon sperm
DNA and washes were done in 10 mM Tris, pH 7.5, containing 1% SDS.
The largest clone (pC-cc1A) was sequenced and shown to be identical to
the sequence of 
 
l
 
G-cc9 in the region of overlap. Using the sequence of
pC-cc1A, probes were designed to screen the library for clones containing
sequences 5
 
9
 
 and 3
 
9
 
 to pC-cc1A. Similar screens were performed until we
had evidence we had cloned the 5
 
9
 
 and 3
 
9
 
 ends of the message.
 
Sequencing
 
The overlapping cDNA clones were sequenced by fluorescent sequencing
techniques using dye-labeled primers or dye-labeled dideoxynucleotides
(ABI). The reactions were performed according to the manufacturer and
reactions were run on an ABI 373A gel analyzer.
 
1. 
 
Abbreviations used in this paper:
 
 FNIII, fibronectin type III; HMM, hid-
den Markov models. 
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Nested deletions of the clone pC-cc1A were made using Erase-a-Base
(Promega) according to the manufacturer, and the deletion clones were
sequenced.
The templates used to obtain the sequence of the ends of each cDNA
isolated subsequent to pC-cc1A were amplified by PCR. The sequence of
the primers used was as follows: primer 1, 5
 
9
 
-GATGATGAAGATAC-
CCCACC-3
 
9
 
; primer 2, 5
 
9
 
-AGTTGAAGTGAACTTGCGGG-3
 
9
 
; primer
3, 5
 
9
 
-GCGTGTAAAACGACGGCCAGTGATGATGAAGATACCC-
CACC-3
 
9
 
; primer 4, 5
 
9
 
-GCGTGTAAAACGACGGCCAGTAGTTGA-
AGTGAACTTGCGGG-3
 
9
 
. The underlined bases in primers 3 and 4 con-
tain a universal priming site. Primers 1 and 3 are complementary to the
same sequence 5
 
9
 
 of the pACT cloning site, and 2 and 4 are complemen-
tary to the same sequence 3
 
9
 
 of the pACT cloning site. Primer pairs 1 and
4, or 2 and 3, were used to amplify the cDNA insert from each clone and
to add the universal priming site to the 5
 
9
 
 or the 3
 
9
 
 end of the amplification
products. The products were treated with 0.2 units exonuclease I (United
States Biochemicals) and 0.2 units shrimp alkaline phosphatase (United
States Biochemicals) for 45 min at 37
 
8
 
C to degrade the unused primer (57)
and the enzymes were inactivated for 20 min at 80
 
8
 
C. The products were
then sequenced directly. This technique was also used to obtain the se-
quence of exons 6–9 and 13. These exons were not encoded by any of the
cloned cDNAs but were thought to be expressed due to the high degree of
homology between the 
 
C
 
.
 
 elegans
 
 and 
 
C
 
.
 
 briggsae
 
 genomic sequences in
these regions. In these cases, templates (RT-PCR 1, 2, and 3; see Fig. 3)
were amplified from the random-primed library using gene-specific prim-
ers complementary to the sequence of the exons flanking the region of in-
terest. As above, one primer used in each reaction was fused to the univer-
sal priming site.
Finally, libraries from each cDNA clone were constructed in the m13
vector to obtain templates to completely sequence each cDNA clone.
Each insert was amplified using PCR and primers 1 and 2 (see above). A
pool of amplification products was fragmented using a nebulizer and 30
psi nitrogen gas (9), treated with mung bean nuclease to generate blunt
ends, and then cloned into the SmaI site of m13. DNA was isolated from
random m13 clones from each library and sequenced.
The sequence obtained was edited for quality using the trace editor
TED (26) and assembled into contigs using XBAP (a sequence assembly
program for X windows; reference 13). The identity of each base was con-
firmed by obtaining the sequence of both strands, by obtaining the base
using two different chemistries (dye-labeled primers or dye-labeled
dideoxy-terminators) or by comparison to the genomic sequence gener-
ated by the 
 
C
 
.
 
 elegans
 
 genome project.
 
Mapping
 
The genomic clone was placed on the physical map by hybridization of a
P
 
32
 
-labeled DNA probe (Prime-It II kit; Stratagene) to YAC clones repre-
senting 
 
z
 
95% of the 
 
C
 
.
 
 elegans
 
 genome (12). The YAC clones are spotted
on a nitrocellulose sheet in a grid pattern. Each YAC represented on the
grid has been ordered into contigs by fingerprint analysis and the contigs
placed into linkage groups representing each 
 
C
 
.
 
 elegans 
 
chromosome.
The 
 
st456 
 
mutation (see Results) was mapped by standard three factor
mapping techniques. Recombinants were cloned from 
 
st456/dpy-1(e1)daf-
2(e1370)
 
 strain, and their progeny were scored to determine where the re-
combination event took place. Recombination took place between 
 
dpy-1
 
and 
 
st456 
 
6 times and between 
 
st456
 
 and 
 
daf-2
 
 twice, placing the mutation
between 
 
dpy-1 
 
and 
 
daf-2
 
.
 
 
 
The 
 
st456
 
 mutation failed to complement a mu-
tation, 
 
let-805(s2764)
 
, isolated in an unrelated lethal screen (Baillie, D.,
personal communication) performed as described by Stewart et al. (49).
This result suggests 
 
st456 
 
is an allele of the 
 
let-805
 
 gene.
 
Protein Analysis
 
Protein similarities were identified using the program BLAST (version
2.0; reference 2) to search the nonredundant protein database and the est
database (dbest) through the NCBI server (search date 8 April 1999).
Searches were also done of an ftp site containing data from the two 
 
C
 
.
 
 ele-
gans
 
 Genome Sequencing Centers (http://genome.wustl.edu).
FNIII repeats were defined using hidden Markov models (HMM) pro-
file (18, 32). The model used is the fn3 HMM from the Pfam protein do-
main database (release 1.0; reference 47). This HMM is based on a multi-
ple alignment of 456 FNIII domains from Swissprot 33. The search was
performed using the programs hmmls and hmnfs from the HMMER hid-
den Markov model software package (17). Alignment scores over 15 bits
(a log odds score, base two) were considered significant.
 
The fn3 model identifies only the first six of the seven 
 
b
 
-strands of the
FNIII repeat. Therefore, a new model was generated to identify the amino
acids that form the seventh strand in each repeat, and to produce the
alignment shown in Fig. 5. The new model was generated using the pro-
gram hmmb (17), and starting with a seed alignment of the four FNIII re-
peats of fibronectin (33). The seed alignment was expanded to include re-
peats identified in the myotactin sequence that had significant scores (in
this case 
 
.
 
20 bits). The expanded alignment was used to generate a new
HMM model. These steps were repeated until no new repeats could be
identified in the myotactin sequence. The 32 repeats identified in this way
were then reanalyzed using the fn3 model and 30 of the 32 repeats had sig-
nificant scores of 
 
.
 
15. The exceptions are repeats 8 and 27 which had
scores of 13.19 and 13.94, respectively.
Secondary structure predictions were made using the program PHD
(43, 44).
 
In Situ Hybridization
 
In situ hybridizations to mixed stage 
 
C
 
.
 
 elegans
 
 embryos were done ac-
cording to the protocol of Seydoux and Fire (45) with a few exceptions.
Embryos were obtained by alkaline hypochlorite treatment of gravid
adults (52) and then treated in batch in microfuge tubes rather than on mi-
croscope slides. After each incubation the embryos were collected by gen-
tle centrifugation. Embryos were fixed in 3% formaldehyde and 0.25%
glutaraldehyde in 85 mM K
 
2
 
HPO
 
4
 
,
 
 
 
pH 7.2 (31).
 
 
 
The probes used were
made by PCR amplification according to Seydoux and Fire (45).
 
Immunological Techniques
 
Embryos were prepared for antibody staining and staged as described in
Hresko et al. (30). Fluorescence was viewed on a Bmax-60F microscope
(Olympus) equipped with Nomarski and fluorescence optics. Images were
taken with a Pentamax camera containing a Kodak KAF-1400 chip (1,317 
 
3
 
1,035) with 6.8-mm pixels (Princeton Instruments). The camera was con-
trolled by an Optiplex GXPro200 computer (DELL Computer Corp.)
running WinView software (v. 1.6.2.1, Princeton Instruments). After ac-
quisition the raw 12-bit WinView images were transferred to a Power
Macintosh computer, linearly scaled to 8-bits ([max pixel value 
 
2
 
 min
pixel value]/256), inverted to conform to the Macintosh intensity scale, re-
duced to 256 shades of gray, and saved as TIFF files using a batch file
conversion program (Spe2Tiff; written by and freely available on request
from waddle@hamon.swmed.edu). Images were assembled and annotated
using Adobe Photoshop 3.0.5 (Adobe Systems, Inc.) and printed on a
Tektronix Phaser 440 printer (Tektronix).
Adult worm fragments were prepared for antibody staining using a
French press as described by Francis and Waterston (21). After fragment-
ing the worms, the pieces were extracted three times for 30 min in 0.5%
NP-40 in low salt buffer (7.5 mM Na
 
2
 
PO
 
4
 
, pH 7.0, 40 mM NaCl, 1 mM
EDTA, and 1 mM PMSF), for 15 min in 0.5 M KSCN in low-salt buffer
and for 15 min in low-salt buffer (22). The extracted fragments were then
fixed for 20 min in 
 
2
 
20
 
8
 
C MeOH. The samples were viewed using a Zeiss
Axioplan microscope equipped for confocal imaging with a Bio-Rad
MRC 1000 laser.
 
Ablations
 
Bodywall muscle precursor cells were ablated at the 28-cell stage using a
nitrogen pulse laser (Laser Sciences, Inc.) as described (3). The beam was
directed through a Zeiss Axioplan microscope with the 100
 
3
 
 objective
and laser intensity was adjusted by the use of neutral density filters. In one
set of experiments MS.ap and MS.pp were ablated and in another set C.ap
was ablated. MS.ap and MS.pp collectively give rise to six anterior body-
wall muscle cells from each dorsal quadrant and three from each ventral
quadrant (51). C.ap gives rise to nine posterior bodywall muscle cells from
the left dorsal quadrant and seven from the left ventral quadrant (51). Af-
ter ablations were performed, the embryos were allowed to develop to a
specific development stage, fixed by freeze fracture (50) and stained with
appropriate antibodies. Confirmation that the correct cell(s) was ablated
was obtained by staining the embryos with an antibody against bodywall
muscle myosin.
 
Mutant Screen
 
The myotactin genomic fragment (from pG-cc9) maps in the physical in-
terval between the 
 
par-2
 
 and 
 
ben-1
 
 genes, corresponding to the region of
the genetic map containing the 
 
dpy-1
 
 gene. We reasoned mutations in the 
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Figure 1. (A) Schematic rep-
resentation of a cross-section
through a threefold stage em-
bryo depicting the spatial re-
lationships between the con-
tractile apparatus of the
bodywall muscle (oval-like
shapes), the muscle basement
membrane (black) and hypo-
dermal fibrous organelles
(hatched areas). Dorsal is to-
ward the top of the page. The
four muscle quadrants are
shown, each consisting of two
rows of muscle cells, with the
long axis of the cells perpen-
dicular to the page. The con-
tractile apparatus is restricted
to the portion of the muscle
cell closest to the muscle cell
membrane facing the hypo-
dermis. Hypodermal fibrous
organelles are restricted to
the region of the hypodermis
adjacent to bodywall muscle
cells. A specialized basement
membrane, positioned be-
tween muscle cells and the
hypodermis, helps to anchor
muscle cells. Myotactin is
thought to be an integral
membrane protein expressed
on the basal hypodermal
membrane with its large ex-
tracellular domain extending
into the basement mem-
brane toward the adjacent
muscle cells. (B) Schematic
representations of the local-
ization of muscle, fibrous or-
ganelle–associated interme-
diate filaments, the MH5
protein and myotactin in dor-
sal views of progressively
older embryos. Intermediate
filament proteins and the
MH5 protein, an immunolog-
ically defined protein that
localizes near fibrous or-
ganelles, show the same
distribution at all develop-
mental stages. Schematics a,
d, and g represent an early
stage of development (just before the start of elongation); b, e, and h represent an intermediate stage (twofold); and c, f, and i represent
a later stage (threefold). In each schematic (a–i) a portion of the two dorsal muscle quadrants is shown. Each quadrant consists of two
rows of mononucleated muscle cells with the long axis of the cells oriented along the anterior-posterior axis of the worm. Anterior is to-
ward the top of the page. Wavy, black, vertical lines mark the lateral edges of the dorsal hypodermis. Horizontal, dashed black lines in
a, d, and g represent the boundaries between adjacent dorsal hypodermal cells. These lines do not appear in b, c, e, f, h, and i because at
these later developmental stages the dorsal hypodermal cells have fused to form a syncytium. Gray areas represent the localization of
components of the muscle cell contractile apparatus (a–c), myotactin (d–f), and the fibrous organelle–associated intermediate filaments
and MH5 protein (g–i). Schematics a–c are focused on the plane of the muscle cells, while d–i are focused on the dorsal hypodermal
cells. Although we discuss only the dorsal surface of the embryo, similar events occur on the ventral surface. At stages earlier than those
shown, muscle cells are adjacent to lateral (seam) hypodermis, and muscle proteins are diffusely distributed in muscle cells. Similarly,
the hypodermal proteins are diffusely distributed in dorsal hypodermal cells. As muscle cells migrate to contact dorsal hypodermal cells,
muscle components accumulate at the membrane where muscle cells contact each other and the hypodermis (a). At about the same
time, myotactin, intermediate filament proteins and the MH5 protein are recruited to specific regions of the hypodermis adjacent to
some muscle cells. Myotactin accumulates adjacent to where the contractile apparatus is forming (d) while intermediate filaments and
the MH5 protein accumulate in a single broad patch in each hypodermal cell adjacent to one muscle quadrant (g). By the twofold stage,
the sarcomeric organization of the obliquely striated muscle is observed (b). At this stage myotactin is still adjacent to the forming con-
tractile apparatus and in fact is organized into rows of dots running oblique to the long axis of the worm and following the oblique stria-
tions of the muscle (e). In contrast, intermediate filaments and the MH5 protein are organized in circumferentially oriented bands that
are restricted to the small regions of the hypodermis adjacent to muscle (h). During the threefold stage, myotactin colocalizes with in-
termediate filaments and the MH5 protein (f and i). 
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myotactin gene might be lethal and screened for lethal mutations linked
to the 
 
dpy-1
 
 gene. Homozygous 
 
dpy-1(e1)
 
 hermaphrodites were mu-
tagenized with 50 mM EMS (ethylmethanesulfonate) (52). Mutagenized
hermaphrodites were mated to wild-type males (N2 strain) and individual
L4 hermaphrodites were cloned from the F1 progeny. The progeny of
each cloned hermaphrodite were examined for the loss of dpy animals,
suggesting a mutagenesis event causing a lethal mutation linked to the
 
dpy-1
 
 gene had occurred in that strain. Embryos from strains segregating
few or no dpy animals were stained with MH46 to identify mutants nega-
tive for the antibody. One mutant was identified. The mutant strain was
outcrossed six times to eliminate other mutations that might be in the
background.
 
Germline Transformation
 
Germline transformation was carried out according to the protocol of
Mello et al. (39). The DNA fragment used is 
 
z
 
30 kb and contains the 
 
C
 
.
 
briggsae 
 
myotactin gene (95% identical to the 
 
C
 
.
 
 elegans
 
 protein), includ-
ing 8 kb upstream of the translational start site and 
 
z
 
2 kb downstream of
the stop codon. This plasmid, along with a plasmid containing the 
 
rol-6
 
gene carrying a dominant mutation, was injected into 
 
dpy-1(e1)let-
805(st456)/qC1
 
 hermaphrodites. The 
 
qC1 
 
chromosome contains a rear-
rangement that suppresses recombination between 
 
dpy-1 
 
and 
 
let-805
 
.
Rolling L4 hermaphrodites were picked 3 d later and their progeny were
examined for the presence of rescued animals by looking for animals with
the dpy phenotype.
 
RNA-mediated Interference
 
Two templates were made from each clone (pC-cc307 and 406) using the
enzyme PWO (Boerhinger Mannhiem Biologicals) and primers homolo-
gous to the vector. The T7 polymerase binding site was added to the 5
 
9
 
end of the coding (template 1) or the noncoding (template 2) strand of the
templates during the amplification (41). Sense and antisense RNA’s were
synthesized from templates 1 and 2, respectively, using mCAP (Strat-
agene) according to the manufacturer. Equimolar amounts of sense and
antisense RNA were annealed to yield double-stranded RNA. The dou-
ble-stranded RNA was injected into hermaphrodites. Hermaphrodites
were allowed to lay eggs for 36 h, then the hermaphrodites were trans-
ferred to new plates. The plates were examined for non–wild-type animals
to determine the phenotype caused by injection of the RNA.
To determine if the phenotype caused by RNA-mediated interference
was similar to that of the 
 
let-805(st456)
 
 homozygotes, embryos were col-
lected 10–15 h after transfer of injected hermaphrodites to new plates and
the arrested embryos were fixed by freeze fracture (50) and stained with
antibodies.
 
Results
 
Myotactin Colocalizes with Hypodermal
Intermediate Filaments
 
Myotactin and fibrous organelle–associated intermediate
filaments colocalize in adult 
 
C
 
.
 
 elegans
 
 worms. Adult
worm fragments were fixed and double labeled with
MH46 to localize myotactin and a rabbit polyclonal anti-
body against intermediate filaments (22), and viewed by
confocal microscopy. The distribution of myotactin and in-
termediate filaments in adult worms is similar (Fig. 2).
Both proteins are organized in thin bands running circum-
ferentially around the worm, and both are restricted to re-
gions of the hypodermis adjacent to muscle and some
mechanosensory neurons. The myotactin- and intermedi-
ate filament-dependent staining within each band is not
uniform, but rather consists of a large number of discrete
punctate structures. Merging of the rhodamine and fluo-
rescein images shows the punctate staining patterns seen
with the two antibodies are coincident as evidenced by the
yellow fluorescence (Fig. 2 C). The correlation between
the distribution of myotactin and intermediate filaments
suggests myotactin localizes close to fibrous organelles.
 
Cloning and Sequencing
 
As a first step in understanding the role myotactin plays in
signaling between muscle and the hypodermis, we cloned a
genomic fragment (pG-cc9) encoding an MH46 epitope
from an expression library (4). We used the cloned ge-
nomic fragment to start cloning a set of overlapping
cDNAs (Fig. 3; see Materials and Methods) extending
from the likely 5
 
9
 
-end to the stop codon. The 5
 
9
 
 most se-
quence obtained encodes eight bases identical to the eight
3
 
9
 
 bases of the SL1 spliced leader, which is trans-spliced to
the 5
 
9
 
 end of many 
 
C. elegans messages, indicating this se-
quence represents the 59 end of the myotactin message.
Figure 2. Confocal images of a wild-type adult worm fragment stained for intermediate filaments (green) and myotactin (red). (A) In-
termediate filaments are concentrated in thin bands running circumferentially around the worm (arrows). The intermediate filament-
dependent staining within each band is not uniform but is associated with discrete punctate structures within the band. (B) Like inter-
mediate filament-dependent staining, myotactin-dependent staining is associated with punctate structures that are organized into bands
(arrows). (C) Merging of the images shown in A and B shows the punctate patterns seen with the two antibodies are coincident and thus
produce the yellow fluorescence.The Journal of Cell Biology, Volume 146, 1999 664
Typically, the first ATG after SL1 encodes the initiator
methionine, and in .90% of the messages examined to
date, the initiator methionine is ,30 nucleotides from the
39 end of SL1 (8). In the sequence presented here, there
are 12 nucleotides separating SL1 and the first ATG which
we have designated as the initiator. The 39 most clone,
pC-cc307, was isolated from an oligo dT primed cDNA
library, and contains sequence identical to that of a 39 ex-
pressed sequence tag (CEMSD21; reference 37), suggest-
ing the sequence encoded by pC-cc307 is close to the 39
end of the message. Furthermore, the sequence encoded
by pC-cc307 and CEMSD21 contains a stop codon at the
end of a long open reading frame beginning with the initi-
ating ATG. This stop codon is followed by sequence con-
sistent with 39 noncoding region with multiple stop codons
in all three reading frames.
While the cDNAs were being sequenced, the genomic
sequence of the Caenorhabditis elegans gene (Chissoe, S.,
personal communication) and a Caenorhabditis briggsae
homologue (Marra, M., personal communication) became
available (the C. elegans genome sequencing project)
which allowed us to define the intron–exon boundaries
over most of the gene (Fig. 3). The exon boundaries are
conserved between the C. elegans and the C.  briggsae
genes with one exception: exons 15 and 16 of the C. ele-
gans gene are encoded by only one exon in the C. briggsae
gene. However, the intron sizes are very different, with the
C. elegans introns generally being larger than the corre-
sponding C. briggsae introns.
Myotactin is predicted to be a large transmembrane pro-
tein. A Northern blot of total RNA from mixed stage
worms probed with the insert from pG-cc9 shows three
RNAs hybridize to the probe, the smallest being z15 kb
(Fig. 4). Furthermore, the longest open reading frame en-
Figure 3. Schematic diagram of the partial myotactin cDNAs and genomic clones. The top two lines represent C. briggsae and C. ele-
gans genomic clones, respectively. Exons are depicted as filled boxes and introns as lines. pG-cc9 is the genomic clone isolated using the
MH46 antibody as a probe (see Materials and Methods) and pC-ccXX(X) are the overlapping cDNA clones. RT-PCR-1, 2 and 3 (see
Materials and Methods) were sequenced to confirm the intron–exon boundaries between exons 5 and 6, 6 and 7, 7 and 8, 8 and 9, 9 and
10, 12 and 13, and 13 and 14. The open boxes at the 39 ends of pC-cc214, pC-cc307, and the C. elegans and C. briggsae genes represent
noncoding sequence. The positions of the predicted translational start (ATG) and the stop codon (TAA) are indicated. pC-cc503 con-
tains eight bases at the 59 end identical to the eight 39 bases of the SL1 spliced leader sequence. Note that exons 6–9, 13, 19A, 19B, 24
and 25 are all differentially spliced. The combinations with which these exons are used has not been determined. The complete se-
quence of the myotactin cDNAs is attainable through Genbank. Two cDNA sequences were submitted: Form A includes exon 19A but
excludes exons 19B, 24, and 25 (accession number AF148954) and form B includes exons 19B, 24, and 25 but excluded 19A (accession
number AF148953). The two forms reflect the differences observed between cDNA pC-cc214 and pC-cc307.Hresko et al. Novel Cell Adhesion Protein of C. elegans 665
coded by the DNA fragments depicted in Fig. 3 predicts a
protein of 4,450 amino acids with a calculated molecular
mass of z498 kD.
Analysis of the hydrophobicity identifies three regions
of the myotactin sequence sufficiently hydrophobic to
insert into the membrane. One at the amino terminus
(amino acids 1–20) probably represents a signal sequence
suggesting the protein is secreted or is a transmembrane
protein. The other two regions, encoded by exons 19A and
B, respectively, are long enough to span the membrane,
and therefore are likely to be transmembrane sequences.
These exons are used alternatively (see Fig. 3) suggesting
at least two protein isoforms are expressed, each with a
different transmembrane domain.
The putative extracellular domain of myotactin contains
at least 32 repeats of z100 amino acids in length with ho-
mology to fibronectin type III repeats (FNIII; Fig. 5) as
identified by a HMM for FNIII domains (47; see Materials
and Methods). Additional sequences (amino acids 331–
425, 559–662, 670–770, 3658–3755, and 3777–3891) con-
tained in the putative extracellular domain may represent
another 5 FNIII repeats. These sequences are not identi-
fied as FNIII repeats by the fn3 model, but are each z100
amino acids in length and are predicted to contain 5–7
b-strands by the secondary structure program PHD (43,
44). This is similar to predictions concerning the secondary
structure of the 32 predicted FNIII repeats and is consis-
tent with the crystal structure of the FNIII repeat (33).
The putative cytoplasmic domain of myotactin has two
serine-rich regions suggesting this sequence might be mod-
ified in response to condition or stimuli. The amino acids
encoded by exons 22–23 and those encoded by exons 26
and 27 are each 14% serine (10/69 and 8/55, respectively),
and those encoded by differentially expressed exons 24 and
25 (see Fig. 3) collectively, are 18% serine (32/173), while
the average protein is only 7% serine (15).
C. elegans myotactin and the presumed orthologue from
C. briggsae appear to be novel transmembrane proteins.
To date, a protein consisting of multiple FNIII repeats and
lacking other known repeat motifs in its extracellular do-
main has not been reported. Furthermore, the cytoplasmic
domain of the protein is unique. The only proteins in the
databases (search date 8 April 1999) with significant simi-
larities to the cytoplasmic domains of the C. elegans and C.
briggsae proteins, are proteins rich in serine and an est en-
try from Onchocerca volvulus, another nematode.
Myotactin Is the MH46 Antigen
Two lines of evidence suggest myotactin is the MH46 anti-
gen. First, the expression of myotactin message is tightly
correlated with the presence of the MH46 epitope. Myo-
tactin message is first detected by in situ hybridization in
embryos before elongation (Fig. 6, A and B). Signal is de-
tected in two groups of cells: one group on the dorsal sur-
face of the embryo flanking the dorsal midline, in the posi-
tion of the dorsal hypodermal cells (Fig. 6 A); and a
second group on the lateral edges of the embryo about
midway between the dorsal and ventral surfaces, in the po-
sition of the ventral hypodermal cells (Fig. 6 B). These two
groups of cells are also positive for the MH46 antibody
(30). Later in development, at about the 1.5–1.75-fold
stage, myotactin message is also detected in the pharynx
(data not shown), a tissue also positive for the MH46 pro-
tein (22).
Similarly, the MH46 protein is not detected in bodywall
muscle (although it appears to colocalize with muscle spe-
cific antigens during some stages of development) and the
myotactin message could not be detected in muscle cells.
In situ  hybridizations were done using a myosin heavy
chain probe to mark the position of the muscle cells and to
show that the muscle cells are accessible to DNA probes
under the conditions used. When myosin message is first
detected, the positive cells are positioned midway between
the dorsal and ventral surfaces, away from the lateral
edges of the embryo (Fig. 6 C), indicating these cells are
not those detected by the myotactin probe at a compara-
ble developmental stage (compare Fig. 6, B and C). Later
in development, the myotactin probe is detected in hypo-
dermal cells at the dorsal and ventral edges of the embryo
(Fig. 6, D and E; arrows). At this stage, myosin is detected
in cells positioned more interiorly (Fig. 6 F). We found no
evidence that myotactin is expressed in bodywall muscle
cells at any developmental stage.
The second line of evidence that myotactin encodes the
MH46 protein is that both the MH46 epitope and an
MH46-negative mutant (st456; see below) map to the same
30 kb of the genome. In wild-type embryos, MH46 staining
is seen along the length of the embryo adjacent to the mus-
cle quadrants (Fig. 7, A and B). In contrast, homozygous
st456 mutants do not show MH46 staining, although the
embryos are positive for myosin and for MH27 (Fig. 7, C
and D), an antibody that recognizes the boundaries be-
tween hypodermal cells (22). To confirm the st456 muta-
tion maps to the region of the genome encoding the myo-
tactin gene, we used a 30-kb fragment of the C. briggsae
genome which encodes a C. briggsae homologue (95%
identical to C. elegans myotactin at the amino acid level)
to rescue the st456 phenotype. All aspects of the pheno-
type described below are rescued by this fragment of
Figure 4. Multiple messages are transcribed
from the myotactin gene, the smallest being
z15 kb. 20 mg of total RNA from mixed
stage worms was run on a 0.7% agarose gel in
the presence of formaldehyde and then trans-
ferred to nitrocellulose. A 32P-labeled DNA
fragment corresponding to the sequence of
pC-cc1A was used to probe the Northern
blot. Molecular weight markers are indicated
at the left, and were determined by either hy-
bridization of the same blot with a twitchin
probe (22 kb; 7) or a dynein heavy chain
probe (14 kb; 35) or by the position of the
28S (3.5 kb) and 18S (1.75 kb) rRNAs of C.
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DNA. A second allele of the gene, s2764,  was isolated
(Baillie, D., personal communication) as described by
Stewart et al. (49), which also fails to stain with MH46 and
fails to complement the allele isolated in this study. The
gene has been designated let-805 (Baillie, D., personal
communication).
Phenotypic Analysis of Myotactin Mutants
The phenotype of let-805(st456) and let-805(s2764) ho-
mozygotes (described below) is likely to be the loss-of-
function phenotype of the let-805 gene. Both mutations
are fully recessive, but more importantly, embryos with a
similar phenotype can be produced by a technique re-
ferred to as RNA-mediated interference (20, 29, 41).
RNA-mediated interference involves injection of wild-
type hermaphrodites with double-stranded RNA homolo-
gous to a gene of interest, and results in progeny with the
loss-of-function phenotype for that gene (see 41 and refer-
ences therein). Wild-type hermaphrodites injected with
double-stranded RNA homologous to pC-cc406 or pC-
cc307, neither of which encodes the MH46 epitope,
produced some progeny that were negative for MH46
suggesting myotactin was not made. Furthermore, these
MH46-negative embryos were indistinguishable from
st456 homozygotes with respect to all the characteristics
described below. These data suggest st456 is a loss-of-func-
tion allele.
Time-lapse video microscopy shows myotactin mutant
embryos have movement and elongation defects. Wild-
type embryos begin to elongate at z300 min after the first
cleavage and elongate three- to fourfold by the time of
hatching at 800 min. At the 1.75-fold stage bodywall mus-
cle contractions begin and are first seen as twitches but
soon the embryo begins to roll vigorously within the egg-
shell (51). Like wild-type embryos, myotactin mutants also
begin to twitch at about the 1.75-fold stage, but unlike
wild-type embryos, the mutants never roll within the egg-
shell. The mutants fail to elongate beyond the twofold
stage, and die before hatching. Since many, if not all muta-
tions that result in failure of embryos to roll also result in
arrest of elongation at the twofold stage (5, 28, 42, 54, 56,
59), the elongation defect associated with myotactin muta-
Figure 5. Alignment of the 32 putative FNIII repeats. With the exception of repeats 8 and 27, the repeats have scores over 15 when an-
alyzed by the fn3 HMM program (see Materials and Methods).Hresko et al. Novel Cell Adhesion Protein of C. elegans 667
tions is probably a secondary consequence of the motility
defect.
The abnormal movement associated with the mutant
myotactin phenotype apparently results from defects in
muscle–cell adhesion. In the homozygous mutants, before
contractions begin, bodywall muscle quadrants extend
from the anterior to the posterior of the embryo (Fig. 7 C),
and the sarcomeric structure of the muscle appears wild-
type. However, at about the time when muscle contrac-
tions begin (1.75-fold stage) the muscle quadrants in the
mutants no longer extend the length of the embryo, indi-
cating that the muscle cells have detached (Fig. 7 E). As
embryogenesis continues, the detachment worsens until
muscle cells are seen only in the mid-section of the embryo
and the normal structure of the contractile apparatus is
lost (Fig. 7 F). Without connection of the muscle to the
exoskeleton, movement is severely impaired.
To ascertain more precisely where the attachment be-
tween the muscle cells and the hypodermis is disrupted in
the mutants, we examined the localization of other com-
ponents of muscle attachment structures. At the time in
development when the muscle cells detach, fibrous or-
ganelle–associated intermediate filaments (Fig. 8 B; see
below) and the MH5 protein (an immunologically defined
protein that localizes close to fibrous organelles [22 and
data not shown]), appear to localize as in wild-type (com-
pare Fig. 8, A and B). By contrast, perlecan, a basement
membrane heparin sulfate proteoglycan synthesized by
bodywall muscle (42), remains associated with the muscle
cells upon their detachment in myotactin mutants (data
not shown). These data suggest the detachment is associ-
ated with a break at the interface between hypodermal
cells and the basement membrane.
Since myotactin in later stages of embryogenesis local-
izes near fibrous organelles, we examined the effect of the
myotactin mutations on the localization of intermediate
filaments (Fig. 8) as well as on the localization of the MH5
protein (data not shown). During early developmental
stages, the localization of both components appears wild-
type in the mutants (compare Fig. 8, A and B). Both are
concentrated in regions of the hypodermis adjacent to
muscle, and both appear to be organizing into the banded
distribution observed for these proteins in older embryos.
However, in mutant embryos some time after elongation
arrest and muscle cell detachment, both intermediate fila-
ments and the MH5 protein become dispersed throughout
the dorsal and ventral hypodermis (Fig. 8, C and D). The
staining seen with either MH4 (Fig. 8 D) or MH5 (data not
Figure 6. Embryonic expres-
sion of the myotactin gene as-
sayed by in situ hybridiza-
tion. Mixed stage embryos
were fixed and incubated
with anti-sense myotactin (A,
B, D, and E) or myosin (C
and F) single stranded DNA
probes labeled with digoxi-
genin. Probes were visualized
using an alkaline-phospha-
tase-conjugated anti-digoxi-
genin antibody. Anterior is
toward the top and in D–F
dorsal is to the right. Arrow-
heads designate dorsal hypo-
dermal cells and arrows des-
ignate ventral hypodermal
cells. (A) Dorsal and (B)
mid-focal plane images of the
same ,290-min embryo. The
anti-sense myotactin probe is
detected on the dorsal sur-
face of the embryo (A) and in
cells at the lateral edges (B)
of the embryo. These cells
are the dorsal and ventral hy-
podermal cells, respectively.
(C) Mid-focal plane of a 300-
min embryo. The myosin
probe is detected in the body-
wall muscle cells giving a dif-
ferent pattern from that of
the myotactin probe (com-
pare to B). (D) Lateral view of a 320-min embryo and (E) lateral view of a comma stage embryo (390 min). Anti-sense myotactin probe
is detected at the dorsal (dorsal hypodermal cells) and ventral (ventral hypodermal cells) edges of the embryo. (F) Lateral view of a 320-
min embryo. The myosin probe is detected in bodywall muscle cells. The positive cells are away from the dorsal and ventral edges of the
embryo. Embryos hybridized with either myosin or myotactin sense probes showed no staining.The Journal of Cell Biology, Volume 146, 1999 668
shown) extends all the way to the boundaries between
dorsal or ventral hypodermis, and seam cells. The precise
correlation of this developmental stage with a wild-type
stage is made difficult by the elongation arrest (elongation
is a ready marker of developmental events in wild-type
embryos). Nonetheless, given the timing of events after
elongation arrest, this is likely equivalent to the wild-type
threefold stage where MH4- and MH5-dependent staining
is restricted to regions of the hypodermis adjacent to mus-
cle (see Fig. 8 A). It is also around this time that the MH46
staining pattern reflects that of the fibrous organelle inter-
mediate filaments.
Although after muscle cell detachment intermediate fil-
aments and the MH5 protein do not remain restricted to
the regions of the hypodermis previously contacted by
Figure 7. Muscle cells detach in let-805(st456) mutant embryos.
Immunofluorescence micrographs of embryos fixed and labeled
with monoclonal antibodies MH46 and MH27 (B and D), or a
polyclonal antibody against myosin (A, C, E, and F). MH27 rec-
ognizes the boundaries between hypodermal cells and is used to
visualize the outline of the embryos. The staining pattern appears
as a grid on the surface of the embryo (B and D, small arrow-
heads). Dorsal is to the left in each case, and large and small ar-
rows mark the posterior and anterior ends of the embryos, re-
spectively. (A–D) Lateral views of a wild-type (A and B) or a
let-805(st456) homozygous (C and D) embryo at the 1.5-fold
stage. Myosin positive cells (A and C) of one dorsal quadrant
(large arrowheads) are seen. In both cases the muscle quadrant
extends from the anterior to the posterior end of the embryo (the
posterior of the quadrant in A is out of the focal plane). Myotac-
tin is localized in the hypodermis adjacent to muscle cells in the
wild-type embryo (B, large arrowheads). No myotactin staining is
detected in the mutant embryo (D). (E and F) Lateral view of let-
805(st456) homozygotes stained for myosin. Note the muscle
quadrants do not extend to the anterior or posterior of either em-
bryo. C, E, and F are images of increasingly older animals show-
ing an increase in severity of the muscle cell detachment over
time.
Figure 8. Wild-type and myotactin mutant embryos stained for
intermediate filaments. Mixed stage embryos were fixed for im-
munofluorescence and labeled with MH4 (intermediate filament
protein) and MH27. MH27 marks the boundaries between hypo-
dermal cells and appears as a grid pattern on the embryos in B
and D. (A and B) Dorsal view of a wild-type (A) and a st456 ho-
mozygous (B) embryo. In both embryos, the MH4-dependent
signal is concentrated in the regions of the hypodermis adjacent
to muscle. (C) Dorsal view of a st456 homozygote older than the
one shown in B. MH4-dependent fluorescence is seen all through
the dorsal hypodermis. (D) Lateral view of an embryo at a simi-
lar stage to the one shown in C. The MH4-dependent staining ex-
tends to the boundaries between the dorsal or ventral hypoder-
mis and the seam hypodermis. The fluorescence pattern seen in C
and D is one of circumferentially oriented bands. Arrowheads
mark the boundaries between dorsal or ventral and seam hypo-
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muscle, they do appear to maintain their association with
the cuticular annuli since the staining pattern seen is regu-
larly spaced, circumferentially oriented bands (Fig. 8, C
and D). As discussed earlier, each fibrous organelle con-
tains two membrane plaques, one associated with the hy-
podermal membrane adjacent to the muscle basement
membrane and one associated with the membrane adja-
cent to the cuticle. The resolution of the light microscope
is not sufficient to distinguish between the two sets, and
therefore it is not clear if both sets, or only the set adjacent
to the cuticle, is present and/or delocalized in the mutants.
Role of Muscle Cells in Fibrous Organelle Assembly
To understand more about how the muscle acts to estab-
lish or maintain the correct spatial relationship between
the contractile apparatus and the fibrous organelles, we
looked at the localization of fibrous organelle intermedi-
ate filaments and myotactin in embryos lacking groups of
muscle cells. We previously suggested that the initial re-
cruitment of these proteins to regions of the hypodermis
adjacent to muscle was initiated by contact between mus-
cle and dorsal or ventral hypodermis (30). To test this
idea, we ablated muscle cell precursors in 28-cell embryos,
allowed the embryos to develop for some time, and then
fixed and stained the embryos with MH4 (to localize inter-
mediate filaments) or MH46 (to localize myotactin). We
ablated either the MS.ap and MS.pp cells, or the C.ap cell,
resulting in the loss of 18 anterior or 16 posterior bodywall
muscle cells, respectively. To assess the success of the ab-
lations, the embryos were stained for myosin (Fig. 9, D
and F). Myotactin protein was absent in regions of the hy-
podermis that normally contact the missing muscle cells,
but was present in regions of the hypodermis adjacent to
the remaining muscle cells (Fig. 9, C and E). Where
present, myotactin appears organized in the obliquely stri-
ated wild-type pattern (Fig. 9 E). The same phenomenon
is seen when ablated embryos are stained for intermediate
filament subunits (data not shown). That is, intermediate
filaments in the ablated embryos are only in regions of the
hypodermis contacting muscle, and appear to be organized
as in wild-type embryos. These results are consistent with
the hypothesis that intermediate filament proteins, myo-
tactin, and possibly other hypodermal proteins organize in
response to a signal produced by bodywall muscle cells.
We do not believe the lack of fibrous organelle staining
in ablated regions of the embryo is due to a lack of expres-
sion of intermediate filament proteins and myotactin. In
wild-type embryos, both proteins are expressed before
contact is made between muscle and dorsal or ventral hy-
podermis (30), making it unlikely that muscle cells are re-
quired for proper expression of these proteins. Instead, we
think the results of the ablation experiments suggest mus-
cle cells are required for recruitment to and/or stabiliza-
tion of these proteins in this region of the hypodermis.
Discussion
Myotactin is a novel transmembrane protein. The se-
quences of the DNA fragments diagrammed in Fig. 3 po-
tentially encode two alternative transmembrane domains
(encoded by exons 19A and B). The putative extracellular
domain consists mainly of at least 32 FNIII repeats and
can be expressed in multiple forms due to differential
splicing. Two alternate cytoplasmic domains are also en-
coded by the gene. The larger predicted cytoplasmic do-
main (encoded by exons 19B–27) is 519 amino acids in
length, and includes an additional 173 amino acids (en-
coded by exons 24 and 25) not found in the shorter form,
18% of which are serines. A search of the nonredundant
protein database using BLASTX (2; search date 8 April
1999) identifies many FNIII repeat–containing proteins,
Figure 9. Myotactin organizes in response to muscle cells. (A)
310-min wild-type embryo stained with MH27 to illustrate the
MH27 staining pattern. (B) An z1.25-fold (z400 min) wild-type
embryo stained with MH27 and MH46. At this stage the MH46
staining extends all the way to the anterior (top) and posterior
(not seen in this focal plane) of the embryo. (C and D) Embryo
ablated for MS.ap and MS.pp at the 28 cell stage, allowed to de-
velop to the 1.25-fold stage, and then fixed and stained for myo-
sin (D) and with MH46 and MH27 (C). (E and F) Embryo ab-
lated for C.ap and allowed to develop to about the twofold stage
and then fixed and stained for myosin (F) and with MH46 and
MH27 (E). (B) Arrows indicate the portion of the staining due to
MH46. (C–F) Arrows mark the position where the truncated
muscle quadrants end, and show the corresponding gap in the or-
ganization of myotactin where hypodermal cells have failed to
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but all of these contain other known extracellular repeat
motifs. Furthermore, the only database entries that show
any significant homology to the putative cytoplasmic do-
main are proteins rich in serine, the presumed orthologue
from C. briggsae (see Results) and an est entry from On-
chocerca volvulus, another nematode.
Analysis of myotactin mutants shows myotactin is re-
quired for muscle–cell adhesion (Fig. 7). Myotactin may
help mediate the attachment by forming part of a link be-
tween specific muscle substructures, such as dense bodies
or M-lines, and the hypodermal membrane. During some
embryonic stages the distribution of myotactin, a hypoder-
mal transmembrane protein, mirrors that of the forming
contractile apparatus (30). This raises the possibility that
a specific muscle substructure may be linked, in part
through myotactin, to specific sites in the hypodermal
membrane. Myotactin, which is anchored in the hypoder-
mal membrane, has the potential to span the basement
membrane and interact with a muscle membrane protein.
Based on crystallographic data, the length of a FNIII
repeat is z35Å (33). The 32 predicted FNIII repeats of
the extracellular domain of myotactin could extend over
110 nm, or long enough to span the basement membrane,
which has been estimated from electron micrographs to be
only z20 nm wide (58).
If myotactin does indeed interact with the muscle mem-
brane, it is of interest to identify the muscle-associated
protein to which it binds. Although the distribution of in-
tegrin and perlecan make them likely candidates to inter-
act with myotactin, we do not believe this is the case. In-
tegrin (encoded by the pat-3 gene; reference 25, 59) is a
transmembrane receptor positioned at the base of each
dense body and M-line (21), and perlecan is a basement
membrane proteoglycan concentrated at these same sites
(21). However, in integrin and perlecan mutants, myotac-
tin is associated with muscle cells, suggesting myotactin–
muscle interactions are not dependent solely on either
integrin or perlecan (30). Although myotactin is not or-
ganized in oblique striations in integrin and perlecan
mutants (30), we think this reflects the loss of muscle
structure in the two mutants rather than the loss of a myo-
tactin-binding protein. Thus, early myotactin organization
depends on muscle organization.
The initial association between muscle and fibrous or-
ganelles is evident when muscle cells migrate onto dorsal
or ventral hypodermis and hypodermal proteins organize
in response to the contact. During wild-type development,
upon contact between muscle and dorsal or ventral hypo-
dermis, intermediate filaments and myotactin accumulate
in the region of the hypodermis adjacent to muscle (see
Fig. 1 B). Embryos missing certain groups of muscle cells,
due to ablation of one or more muscle precursor cells, fail
to accumulate these proteins adjacent to the region the
missing muscle cells should occupy. This suggests a signal
from the muscle cells is required to recruit certain pro-
teins, including some fibrous organelle–associated pro-
teins, to regions of the hypodermis adjacent to muscle.
Myotactin is not involved in receiving the signal from
muscle that establishes the association between muscle
and fibrous organelles. In myotactin mutants, fibrous or-
ganelle–associated intermediate filament proteins and the
MH5 protein, both accumulate in regions of the hypoder-
mis adjacent to muscle upon contact between muscle, and
dorsal or ventral hypodermis. Only later in development,
after the time contraction normally begins, do the hypo-
dermal proteins in the mutants become delocalized and no
longer restricted to the regions overlying muscle. The fi-
brous organelles do however remain associated with the
cuticular annuli.
Myotactin May Be Required to Maintain the 
Association between Muscle and Fibrous Organelles
Fibrous organelles become delocalized in myotactin mu-
tants. In embryos homozygous for the st456 mutation, the
localization of intermediate filaments and the MH5 pro-
tein appears wild-type until late in embryogenesis when
both are seen all through the dorsal and ventral hypoder-
mis. We believe the distribution of intermediate filaments
and the MH5 protein in myotactin mutants reflects the dis-
tribution of fibrous organelles for two reasons. First, al-
though unlike in wild-type embryos the two proteins are
not restricted adjacent to muscle, they do codistribute with
one another, and both remain associated with cuticular an-
nuli (see Fig. 8) as in wild-type embryos. Second, the dis-
tribution of the two proteins appears wild-type through
the embryonic stages when the fibrous organelles form.
We suggest that in the myotactin mutants, the fibrous or-
ganelles at least partly assemble as in wild-type, but in the
absence of myotactin may be allowed to move within the
membrane. Movement of another membrane-associated,
intermediate filament anchoring structure, the vertebrate
hemidesmosome, has been shown by treating 804G cells
with cytochalasin D to disrupt the actin cytoskeleton (40).
Hemidesmosomes were located subjacent to the nucleus
before cytochalasin treatment, but in as little as 30 min af-
ter addition of the drug, hemidesmosomes were found at
the cell periphery in cell projections. These peripheral
hemidesmosomes were associated with cytoplasmic inter-
mediate filaments and with the transmembrane hemides-
mosome-associated protein BP180. The speed of the effect
suggests relocation of hemidesmosomes is due to move-
ment of a complex of proteins rather than to disassembly
and reassembly of the structures (40).
One possibility is that muscle cell detachment is respon-
sible for the delocalization of fibrous organelles in myotac-
tin mutants. However, observations of fibrous organelle–
associated proteins in contractile mutants argue this is
probably not the case. Examination of myosin A and tro-
pomyosin mutants, where muscle cells cannot contract and
appear to remain attached to the hypodermis at the ante-
rior and posterior of the embryo, revealed that fibrous or-
ganelles also become delocalized (Hresko, M., and R.H.
Waterston, unpublished results). Delocalization of fibrous
organelles is clear even in the regions of the hypodermis
where the muscle cells appear to remain attached. Inter-
estingly, in both myotactin and contractile mutants, delo-
calization of fibrous organelles occurs during what might
be equivalent to the wild-type threefold stage. This is the
stage when the distribution of myotactin first reflects that
of fibrous organelles. Perhaps the localization of myotac-
tin to the hypodermal membrane at or near fibrous or-
ganelles is important for restricting fibrous organelles at
this stage. The delocalization observed in the myotactinHresko et al. Novel Cell Adhesion Protein of C. elegans 671
mutants would therefore occur because myotactin is ab-
sent.
An alternative possibility is that, in the myotactin mu-
tants, the delocalization of fibrous organelles occurs be-
cause only the membrane plaques adjacent to the cuticle
are present. As discussed earlier, each fibrous organelle
consists of two membrane plaques, one at the membrane
adjacent to muscle and one at the membrane adjacent to
the cuticle. Possibly, in the absence of myotactin, the
plaques adjacent to the muscle either do not assemble, or
assemble but then disassemble. Due to the absence of the
plaques adjacent to muscle, the ones adjacent to the cuti-
cle are not restricted to regions of the hypodermis ad-
jacent to muscle and become delocalized. Since in the
myotactin mutants fibrous organelle proteins initially con-
centrate in regions of the hypodermis adjacent to muscle,
and in fact fibrous organelles appear to assemble in these
regions of the hypodermis, we think it is unlikely that the
plaques adjacent to muscle do not form. Therefore, it
seems more likely that myotactin helps in maintaining the
correct spatial relationship between muscle and fibrous or-
ganelles either by maintaining the integrity of the fibrous
organelle structures and preventing their disassembly, or
by restricting the movement of fibrous organelles within
the hypodermal membrane.
Therefore, we favor a model in which myotactin is es-
sential to maintain the correct spatial relationship between
the contractile apparatus of the bodywall muscle and the
fibrous organelles of the hypodermis. In this model, during
wild-type development, myotactin is synthesized and se-
creted by the dorsal and ventral hypodermal cells, but re-
mains attached to the hypodermis through a transmem-
brane domain. As muscle cells migrate and contact the
dorsal and ventral hypodermis, the extracellular domain of
myotactin extends and interacts with a muscle-associated
protein. The interaction between muscle cells and the hy-
podermal membrane, made through myotactin, is required
to prevent detachment of muscle cells when contractions
first begin. At some time during development, the distri-
bution of myotactin becomes correlated with the position
of fibrous organelles. Myotactin, due to its association
with muscle and close proximity to fibrous organelles,
would help maintain the correct spatial relationship be-
tween the muscle contractile apparatus and the fibrous or-
ganelles. This might serve to strengthen the connection be-
tween the hypodermis and the muscle.
The resolving power of the light microscope does not al-
low us to determine if myotactin is a fibrous organelle
component. However, if myotactin does interact with fi-
brous organelles, it may do so only later in development
(during the threefold stage), suggesting the association is
regulated in some way. Based on the sequence presented
in this paper, there are at least two ways in which this reg-
ulation might occur. First, regulation might occur through
the use of different isoforms. The gene encodes eight dif-
ferentially used exons which allow for myotactin isoforms
that differ in the extracellular, the transmembrane, and
the cytoplasmic domains. The sequence encoded by these
exons might be important for positioning myotactin near
fibrous organelles. The second mechanism by which an as-
sociation between myotactin and fibrous organelles might
be regulated is through phosphorylation. The carboxyl end
of the putative cytoplasmic domain is enriched in serine
residues. Phosphorylation of these regions might alter the
function of the myotactin molecule.
Interestingly, a vertebrate transmembrane hemidesmo-
some-associated protein, BP180 (27, 34), that shares no se-
quence similarity to myotactin, may serve a role similar to
that of myotactin. A human patient with GABEB (gener-
alized atrophic benign epidermolysis bullosa) has been
described who has a different mutation in each allele of
his/her BP180 gene (38). In this patient, hemidesmo-
somes form as do the anchoring filaments that secure the
hemidesmosomes to the connective tissue below. How-
ever, the lamina lucida, the junction between the epithe-
lium and the dermis, is widened as if the strength of the
connection between the hemidesmosomes and the anchor-
ing filaments was not sufficient to keep the epithelium at-
tached (38). This result suggests BP180, like myotactin,
may be responsible for strengthening the connection be-
tween the membrane at or near a cell adhesion structure,
and the basement membrane. While it is known that b4a6
integrin forms a link between hemidesmosomes and the
basement membrane (16, 24, 46, 53), the existence of mu-
tations in transmembrane proteins (BP180 or myotactin)
other than integrin which result in detachment at epi-
dermal-basement membrane junctions suggests there are
multiple links between cell adhesion structures and the
basement membrane or dermis. Furthermore, in mice
lacking  b4 (16, 53) or a6-integrin (24), there are some re-
gions of the skin where the basal epithelial cells have not
detached from the dermis, again suggesting b4a6 integrin–
independent links exist between the epithelium and the
basement membrane. Whether BP180 and myotactin per-
form analogous functions of anchoring cell adhesion com-
plexes in specific regions of the membrane awaits further
study as does elucidation of mechanisms by which these
types of proteins might function.
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